This paper investigated the effects of cerebrospinal fluid (CSF) volume during storage (different ratios of storage tube surface area and CSF volume) on the quantification of four Alzheimer's disease biomarkers measured on an automated immunoassay analyzer.
Impact of CSF storage volume on the analysis of Alzheimer's disease biomarkers on an automated platform.
Delaby C, Muñoz L, Torres S, Nadal A, Le Bastard N, Lehmann S, Lleó A, Alcolea D
Purpose
Conclusion
Measurements of the Aβ1-42 and Aβ1-40 biomarkers were significantly affected by storage at lower volumes (higher surface/volume ratios) but these discrepancies were partially compensated for when measuring the Aβ1-42/Aβ1-40 ratio. In contrast, t-Tau and p-Tau measurements did not differ based on storage volume.
Studies (1)
Purpose
This study investigated the effects of CSF volume during storage (different ratio of surface area to CSF volume) on the quantification of four Alzheimer's disease biomarkers measured on an automated immunoassay analyzer. CSF was collected from 10 patients undergoing lumbar puncture into 10 ml polypropylene tubes. Specimens were immediately centrifuged at 2000 x g for 10 min at 4 °C, aliquoted into 2 mL polypropylene tubes at four different volumes (1.5 mL, 1 mL, 0.5 mL, and 0.25 mL), and then stored at −80°C until analyses (<4 weeks). Concentration of Aβ1-42, Aβ1–40, t-Tau, and p-Tau were measured using the LUMIPULSE G600II automated platform and results were presented as percentage relative to the reference sample (1.5 mL).
Summary of Findings
Measurements of the Aβ1-42 and Aβ1-40 biomarkers were significantly affected by storage at lower volumes (higher surface/volume ratios) with Aβ1-42 levels 7%, 15%, and 21% and Aβ1-40 levels 4%, 8%, and 10% lower in CSF specimens stored at 1 mL, 0.5 ml, and 0.25 mL aliquots; respectively, compared to the 1.5 mL reference specimen (P<0.05, P<0.001, P<0.001, P=0.06, P<0.001, and P<0.001; respectively). These discrepancies were partially compensated for when measuring the Aβ1-42/Aβ1-40 ratio which resulted in levels 8% and 12% lower in 0.5 mL and 0.25 mL aliquots compared to the reference aliquot (P<0.001 and P<0.001, respectively) and no significant difference in the 1 mL aliquot (P=0.11). In contrast, t-Tau and p-Tau measurements did not differ based on storage volume.
Biospecimens
FluidCerebrospinal FluidPreservation Types
FrozenDiagnoses
Alzheimer's DiseasePlatforms
ProteinChemiluminescence immunoassayPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Aliquots and Components Aliquot size/volume 0.25 mL0.5 mL1 mL1.5 mL